PT-141

DRAGON PHARMA PT-141

PT-141, also known as Bremelanotide, is a melanocortin receptor agonist used to enhance sexual desire and arousal. Developed by Dragon Pharma, this product contains 10 mg of Bremelanotide per vial and comes in a 2 mL vial. Unlike traditional hormone-based treatments, PT-141 works directly on the central nervous system, making it effective for increasing sexual desire without affecting testosterone or estrogen levels. While primarily designed for treating hypoactive sexual desire disorder (HSDD), PT-141 has also gained popularity among athletes and bodybuilders looking to enhance their overall well-being.

DRUG COMPOSITION

Active substance: Bremelanotide (10 mg per vial)
Excipients: Stabilizers and bacteriostatic water for injection.

PHARMACEUTICAL FORM

PT-141 is provided as a lyophilized powder that must be reconstituted with bacteriostatic water for subcutaneous injection.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical Group: Melanocortin receptor agonist
ATC Code: G04BE (Drugs used for sexual dysfunction)

PHARMACOLOGICAL PROPERTIES

PT-141 works by activating melanocortin receptors in the brain, which are involved in regulating sexual desire and arousal. Unlike phosphodiesterase type 5 inhibitors (such as Viagra), which primarily affect blood flow, PT-141 acts on the central nervous system, improving libido and arousal. It is highly effective for both men and women and offers a natural way to boost sexual desire without hormone-based interventions.

PROFILE

• Chemical name: Bremelanotide (formerly PT-141)
• Chemical formula: C50H68N14O10
• Percentage of anabolic activity: None
• Percentage of androgenic activity: None
• Active half life: Approximately 2.7 hours
• Recommended dosage: 1.75 mg administered via subcutaneous injection as needed
• Acne: None
• Bloating (water retention): Unlikely
• HBR: Possible (caution advised in patients with cardiovascular conditions)
• Hepatic toxicity: None
• Aromatization: None

THERAPEUTICAL INDICATIONS

PT-141 is primarily indicated for individuals suffering from hypoactive sexual desire disorder (HSDD). It is also used off-label by athletes and bodybuilders to improve mood, well-being, and performance by enhancing sexual desire and energy levels, making it useful during demanding training cycles.

DOSES AND METHOD OF ADMINISTRATION

The typical dosage for PT-141 is 1.75 mg, administered via subcutaneous injection. It is recommended to inject it approximately 45 minutes before the desired effect. Adjustments in dosage may be made based on individual response and goals.

CYCLE/STACKING

Although PT-141 is not typically stacked for anabolic purposes, it can be paired with other Dragon Pharma products for overall well-being:

• Cycle for Mood and Well-being (8-12 weeks):

  • PT-141: 1.75 mg as needed
  • Stack with Oxytocin to further enhance mood and reduce stress.
  • Combine with Testosterone to support sexual health during anabolic cycles.

• Recovery Cycle (8-12 weeks):

  • PT-141: 1.75 mg as needed
  • Stack with CJC-1295 DAC to promote recovery and improve overall well-being.

POST CYCLE THERAPY

PT-141 does not require post-cycle therapy as it does not suppress natural hormone production. It can be safely used on its own or in conjunction with other performance-enhancing agents.

SIDE EFFECTS

The most common side effects of PT-141 include mild nausea, flushing, or headache. These side effects are generally temporary and subside shortly after administration. In rare cases, users may experience increased blood pressure or dizziness.

CONTRAINDICATIONS

PT-141 is contraindicated in individuals with cardiovascular disorders, as it may elevate blood pressure. Pregnant or breastfeeding women should avoid using this product. Consult a healthcare provider before use, especially if you have pre-existing health conditions.

OVERDOSE

Overdosing on PT-141 may lead to more pronounced side effects such as severe nausea, vomiting, or increased blood pressure. In case of overdose, discontinue use and seek medical attention.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

PT-141 should be used cautiously by individuals with high blood pressure or heart disease. Avoid exceeding the recommended dosage, and always consult with a healthcare provider if combining PT-141 with other medications.

INTERACTIONS WITH OTHER DRUGS

PT-141 may interact with medications used to treat cardiovascular conditions or other drugs that affect blood pressure. Consult a healthcare provider before using PT-141 in conjunction with other medications.

PRESENTATION, PACKAGING

PT-141 by Dragon Pharma is available in 2 mL vials containing 10 mg of lyophilized Bremelanotide. The packaging ensures safe delivery and maintains product stability.

STORAGE

Store PT-141 in a cool, dry place away from direct sunlight. Once reconstituted, keep refrigerated and use within 30 days. Keep out of reach of children.

DELIVERY TO THE USA

We offer fast, discreet, and secure delivery of Dragon Pharma PT-141 to the USA. All orders are packaged carefully to ensure privacy and timely arrival.

LEGAL STATUS

PT-141 is FDA-approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. For bodybuilding or performance enhancement, it is considered off-label, so be sure to check local regulations before purchasing.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• Bremelanotide Wiki, wikipedia.org
• Bremelanotide Injection: MedlinePlus Drug Information, medlineplus.gov